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Abstract
Cantú syndrome (CS) was first described in 1982, and is caused by pathogenic vari-
ants in ABCC9 and KCNJ8 encoding regulatory and pore forming subunits of ATP-
sensitive potassium (KATP) channels, respectively. It is characterized by congenital
hypertrichosis, osteochondrodysplasia, extensive cardiovascular abnormalities and
distinctive facial anomalies including a broad nasal bridge, long philtrum, epicanthal
folds, and prominent lips. Many genetic syndromes, such as CS, involve facial anoma-
lies that serve as a significant clue in the initial identification of the respective disor-
der before clinical or molecular diagnosis are undertaken. However, an overwhelming
number of CS patients receive misdiagnoses based on an evaluation of coarse facial
features. By analyzing three-dimensional images of CS faces, we quantified facial dys-
morphology in a cohort of both male and female CS patients with confirmed ABCC9
variants. Morphometric analysis of different regions of the face revealed gender-
specific significant differences in face shape. Moreover, we show that 3D facial photo-
graphs can distinguish between CS and other genetic disorders with specific facial dys-
morphologies that have been mistaken for CS-associated anomalies in the past, hence
assisting in an earlier clinical and molecular diagnosis. This optimizes genetic counseling
and reduces stress for patients and parents by avoiding unnecessary misdiagnosis.
K E YWORD S
3D imaging, Cantú syndrome, dense surface model (DSM), dysmorphology, facial
phenotyping, principal component analysis (PCA)
1 | INTRODUCTION
Cantú syndrome (CS; OMIM #239850) is a rare autosomal dominant
condition characterized by a wide constellation of clinical features,
namely coarse facial features, congenital hypertrichosis, osteochon-
drodysplasia and extensive cardiovascular anomalies including card-
iomegaly, patent ductus arteriosus (PDA), pericardial effusion and
dilated and torturous cerebral blood vessels (Grange et al., 2019;
Grange, Lorch, Cole, & Singh, 2006; Leon Guerrero et al., 2016; Scurr
et al., 2011). CS is caused by gain-of-function (GoF) pathogenic variants
in ABCC9 and, less commonly, in KCNJ8, which encode the regulatory
(SUR2) and pore-forming (Kir6.1) subunits, respectively, of ATP-sensitive
potassium (KATP) channels(Brownstein et al., 2013; Cooper et al., 2014;
Harakalova et al., 2012; McClenaghan et al., 2017; van Bon et al., 2012).
Notably, a majority of cases are considered to harbor de novo variants.
Remarkably, there is considerable variation in the phenotypic
spectrum, even within family members sharing the same ABCC9 vari-
ant (Roessler, Volker-Touw, Terhal, van Haaften, & van Haelst, 2018).Peter Hammond and Mieke M. van Haelst contributed equally
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The underlying reason for this heterogeneous clinical presentation is
still unclear.
Dysmorphic facial features, on the other hand, are observed in
every CS patient and are usually evident at birth. In younger patients,
features include a low frontal hairline, epicanthal folds, flat nasal
bridge, anteverted nares, long philtrum, macroglossia, prominent
mouth, and thick lips. Additionally, the palate may be high arched
and/or narrow, the gingiva may be thickened and an anterior open
bite may be present (Grange et al., 2019). With advancing age, how-
ever, these clinical features are subject to considerable phenotypic
changes. Whereas the initial facial shape appears round with full
cheeks, the facial phenotype progresses to a lengthening of the face
with a pointed chin and a more prominent forehead (Scurr et al.,
2011). Progressive coarsening of the face results in further flattening
of the nasal bridge with prominent supra-orbital ridges and fuller lips.
The small nose becomes more bulbous. Periorbital fullness seems to
be consistent (Roessler et al., 2018).
Despite the identification of ABCC9 and KCNJ8 pathogenic vari-
ants as being causal, an explanation for variability of CS-associated
features remains unknown. The correlation between GoF mutations
in KATP channels and the coarse facial appearance is currently still not
understood. Additionally, in a recent report describing 74 patients in
the International Cantú Syndrome Registry (ICSR) we were unable to
correlate genotype to specific phenotypic features in CS individuals
including facial appearance (Grange et al., 2019).
Facial dysmorphism plays an important role in the clinical diagno-
sis of genetic conditions such as CS since it often presents as a prelim-
inary clue before clinical examination and molecular genotyping are
undertaken. Since the genes associated with CS have only recently
been identified and not all patients have had adequate genetic
counseling and investigation, we suspect that there is still a large num-
ber of undiagnosed or misdiagnosed cases. Additionally, the low inci-
dence of CS limits exposure during training of clinical geneticists and
inhibits the development of skills in recognizing the facial features
characteristic of this syndrome. An overwhelming number of CS
patients initially received other diagnoses, often based on coarse facial
features with mucopolysacharidosis being most common; an unneces-
sary and stressful process for parents (Grange et al., 2019). Hence,
quantitative analysis of the described facial morphology is of vital
importance in characterizing the phenotype, which will assist in
achieving earlier clinical and molecular diagnosis and thus optimizing
appropriate medical care and genetic counseling.
Three-dimensional (3D) surface imaging systems have already
been successfully applied in a range of clinical situations such as burns
(Kovacs et al., 2005), dermatology (Ardehali et al., 2007) and ortho-
dontics (Hajeer, Millett, Ayoub, & Siebert, 2004). Rapid, noninvasive
3D imaging enables the face to be viewed from any angle and at
closer proximity than most children, or even adults, would tolerate
with a human observer. Consequently, 3D face analysis using dense
surface modeling (DSM) has proven successful in delineating facial
morphology in Williams syndrome (WS; OMIM # 194050)
(Hammond & Suttie, 2012), Noonan syndrome (NS; OMIM #163950)
(Hammond, 2007), Wolf–Hirschhorn syndrome (WHS; OMIM
#194190) (Hammond et al., 2012) and Smith–Magenis syndrome
(SMS; OMIM #182290) (Tomona, Smith, Guadagnini, & Hart, 2006),
establishing accurate discriminating characteristics or assisting the
determination of phenotype–genotype correlations. In addition,
computer-based models of 3D facial morphology can assist in dys-
morphology training (Hammond, 2007).
In the present study, we investigated the effect of CS-associated
mutations in ABCC9 on craniofacial structures using DSM based
analysis of 3D photographs of 20 clinically affected and molecularly
proven CS patients. Additionally, we compared facial dysmorphism in
CS with genetic disorders that can be a differential diagnosis of CS
because of overlapping facial features. Our study assembles the
second largest cohort of CS patients studied so far, considering the
overall rareness of the disorder (Grange et al., 2019).
We demonstrate that DSM-based analysis provides a very accu-
rate instrument to classify faces or facial regions along the CS-control
spectrum. In addition, we highlight specific facial differences between
CS and genetic disorders with similar dysmorphisms to improve initial
diagnosis of these patients. As a result, our findings demonstrate the
utility of 3D imaging during a genetic diagnostic process.
2 | SUBJECTS AND METHODS
2.1 | Study participants
All data reported here were collected after informed written consent
of the patient or the parents or legal guardians for patients younger
than 18 years old.
The CS patients group comprised 10 male patients 2.7–16.2 years
old and 10 female patients 3.1–22.0 years old. Figure S1 shows distri-
bution of country of origin over age in CS patients. All patients had
been molecularly diagnosed with CS either by Sanger-sequencing of
the ABCC9 gene or whole exome sequencing. All study participants
are part of the ICSR and have been reported previously at least once
(Grange et al., 2019). 3D face images of individuals with CS were col-
lected during special annual Cantú syndrome research clinics at the
Utrecht University Medical Center, the Netherlands, and at
Washington University, St. Louis, MO. The accuracy of such 3D imag-
ing devices has been shown to be highly reliable (Aldridge, Boyadjiev,
Capone, DeLeon, & Richtsmeier, 2005; Camison et al., 2018). Some
images were unusable because of incomplete face coverage or poor
subject cooperation. Details of the specific ABCC9 variants and body
weight and height were obtained from the ICSR (Grange et al., 2019).
Images of healthy subjects as well as patients diagnosed with Wil-
liams syndrome (WS), Fabry disease (FD), Rubinstein–Taybi syndrome
(RTS) and Rasopathies were selected from an existing collection.
Dense surface models (DSM) were constructed with the following
number of individuals to get the fullest face shape variation possible:
Healthy controls included 183 unrelated male patients 0.2–66.5 years
old and 173 unrelated female patients 0.3–62.2 years old; WS cohort
included 51 unrelated male patients 1–17 years old and 41 unrelated
female patients 1.1–19.7 years old; FD cohort included 30 unrelated
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male patients 3.4–64.4 years old and 38 unrelated female patients
5.8–71.5 years old; RTS cohort included 18 unrelated male patients
2–31 years old and 23 unrelated female patients 1.2–31 years old;
Rasopathies cohort included 31 unrelated male patients 1.7–26.4 years
old and 40 unrelated female patients 0.9–47.6 years old. However, only
age- and sex-compatible subgroups were used during analysis.
For comparison with all male and female CS patients the sample
size and age range was as follows: healthy male controls, n = 76
(age range: 3.1–21.0 years); healthy female controls, n = 69 (age
range: 2.4–22.4 years old); male WS patients, n = 45 (age range: 2.1–
17 years); female WS patients, n = 38 (age range: 2.3–19.7 years);
male FD patients, n = 10 (age range: 3.4–22.7 years); female FD
patients, n = 18 (age range: 5.8–22.8 years); male RTS patients, n = 15
(age range: 2.0–17.9 years); female RTS patients, n = 19 (age range:
2.4–21.6 years); male Rasopathies patients, n = 15 (age range: 2.4–
22.4 years); female Rasopathies patients, n = 18 (age range: 2.3–
21.9 years old). For comparison with age-specific male and female CS
subgroups the sample size and age range was as follows: male CS sub-
groups, n = 4 (age range: 2.7–5.1 years); n = 6 (age range: 10.8–
20.8 years); female CS subgroups, n = 3 (age range: 3.1–5.5 years);
n = 7 (age range: 10.0–22.0 years); male healthy controls, n = 17 (age
range: 3.1–5.8 years); n = 36 (age range: 10.0–21.0 years); female
healthy controls, n = 20 (age range: 2.5–5.8 years); n = 25 (age range:
10.0–22.4 years); WS, n = 26 (age range: 2.1–5.9 years), n = 35 (age
range: 10.5–19.7 years); FD, n = 3 (age range: 3.4–5.8 years), n = 19
(age range: 10.1–22.8 years); RTS, n = 11 (age range: 2.0–5.5 years),
n = 12 (age range: 10.2–21.6 years); Rasopathies, n = 18 (age range:
2.3–5.8 years), n = 28 (age range: 10.5–22.4 years).
All individuals used in this study are Caucasian but from different
countries of origin. Figure S2 shows distribution of country of origin
of controls and patients with another disorder used in this study.
Notably, the mutation profile of all age-matched rasopathies
patients is as follows: HRAS (n = 12), BRAF (n = 11), PTNP11 (n = 6),
MEK1 (n = 2), KRAS (n = 1), SOS1 (n = 1).
2.1.1 | 3D image capture and preparation
A total of 20 3D face images of individuals with CS were captured
with commercial photogrammetric devices (3dMDface System [3dMD
Inc.] and Canfield Vectra 3D system [Canfield Scientific Inc.]). All
images were manually annotated by a single operator (PH) with
22 facial landmarks previously shown to be accurate and reproducible
(Toma, Zhurov, Playle, Ong, & Richmond, 2009).
2.2 | DSM building and closest mean classification
A dense surface model of a set of landmarked face surfaces, described
in detail elsewhere (Hammond, 2007; Hutton, Buxton, Hammond, &
Potts, 2003), comprises shape variation modes arising from a principal
component analysis (PCA) of differences of the surface points' positions
from those of a comparator average face. Prior to the PCA, using a base
mesh (whole face or patch) and aligned sparse landmarks, a dense cor-
respondence of surface points across all faces is induced with no man-
ual interaction. The proportion of face shape variance covered by each
DSM mode is computed, and typically the modes are ordered in terms
of decreasing variance coverage. For a DSM of a collection of faces of
children and adults, the first mode typically reflects facial growth and
correlates strongly with age (Hammond, 2007). We retained sufficient
modes to cover 99% of shape variance in each constructed DSM.
Each face surface captured has as many as 30,000 mesh points.
The signature of a face surface is the set of position differences at
constituent image mesh points from corresponding points on the
mean of age/sex-matched healthy controls, normalized against the
variation in controls. The signature weight of a surface is the square
root of the sum of the squared normalized differences across all of
the densely corresponded points. Signature weight is a rough estimate
of facial dysmorphism. A signature heat map visualizes the significance
of localized differences using a red-green-blue spectrum with, for
example, red and blue reflecting extreme opposite displacements and
green coincidence with the mean of the matched controls. Thus, an
axis normal to the face surface reflects inward/outward displacement.
In order to investigate differences in face shape, we used multi-
folded discrimination testing (closest mean; support vector machines;
linear discriminant analysis) to determine baseline discrimination rates
between controls and syndromes. Anthropometric comparisons were
made against appropriate age-range matched controls.
2.2.1 | Comparison of linear regressions
Linear regressions were undertaken for various facial measurements
and DSM-based markers against age. Prism (Graphpad) was used to
determine significant differences in slope and/or intercept in compari-
sons of separate regressions for control, CS and other disorder cohorts.
2.2.2 | Statistical analysis
Significance values when comparing gender-specific facial features of
CS patients and controls were calculated using an unpaired Student's
t-test throughout the article. Statistical robustness was further
enhanced through applying a Bonferroni correction that divides the p-
value cut-off by the number of tests run. To find statistically signifi-
cant differences in facial features between male and female CS
patients and age- and gender-matched controls, 5% p-value cut-off
was divided by 4, resulting in a threshold p-value of .0125.
3 | RESULTS
We present 3D imaging analysis in 20 CS patients. All patients have
confirmed genetic variants in ABCC9 (Figure S2); in 17/20 patients
this variant is de novo. Information regarding genotype and general
features of all 20 patients is provided in Table 1. Clinical phenotype
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among patients was similar to those reported in previous studies.
Table S1 lists major clinical features of CS found in the study partici-
pants. All patients are part of the ICSR (Grange et al., 2019) and thus
have been published at least once before. Patient study numbers applied
in this study can be traced back to the ICSR published by Grange et al.
(2019), which documents clinical features of each patient in detail.
3.1 | Patient demographics
The 20 patients (10 females and 10 males) range in age from 2.7 to
22.0 years (mean: 11.46 years) (Table 1). Patients were recruited by
two clinical genetic centers, in the Netherlands and the United
States. All participants are Caucasian and most (17/20) identify as
non-Spanish/Hispanic/Latino, reflecting the location of the partici-
pating sites.
3.2 | Facial dysmorphology in CS
Using software developed in house, a dense surface model (DSM) was
constructed from the landmarked images including 20 CS patients,
272 individuals with a syndrome other than CS (203 age-matched)
and 356 controls (145 age-matched). Approximately 25,000 points on
each face were used in the dense correspondence. The corresponding
DSM contained 40 principal components covering 99% of all shape
variation.
Comparison of the mean faces of the CS and control group con-
firms many of the previously published facial features. In Figure 1, the
mean face of the 20 CS patients (b) and an age-matched control (a) are
shown in portrait and profile. A signature heat map of the mean CS
face reflects location differences between corresponding points on the
mean age-matched control along a surface normal (Figure 1c). Points
on the CS mean face are shown in green if they are coincident with
their corresponding points on the unaffected mean surface. They are
colored red/blue if they are displaced inward/outward relative to the
matched mean control surface on a − 2 to +2 SD scale. The abundance
of blue especially on the nose, lips and mandible of the mean CS face
shows clear differences compared to controls. Signature heat maps of
all 20 CS patients can be found in Figure 1d.
When compared with the age-matched control mean, the mean
CS face shows general lengthening of the face, whereas width seems
to be normal. The nasal bridge appears broader and the nasal tip turns
upwards resulting in anteriorly facing nostrils. The philtrum length is
increased and the lips show general thickening as well as concave
curling of the upper lip. Additionally, epicanthic folds are present
resulting from narrowing of both the supra-orbital arch and notch.
Periorbital fullness is vaguely present. Notably, due to presence of
eyelashes and wetness of eye surfaces, 3D camera devices often lead
to image capture errors, such as holes in the surface or even spikes, or
do not obtain an accurate surface around the eyes, at all.
All DSM analyses were performed for a reduced face patch since
ears were not included during 3D image capture. However, from
previous studies we know that no dysmorphologies of the ears are
expected (Grange et al., 2019).
3.3 | Mean male and female faces and dynamic
morphs
Figures 2 and 3 show static portrait and profile views signature heat
map comparisons between all CS males (n = 10) (Figure 2) or females
(n = 10) (Figure 3) and an age- and sex-matched average of appropri-
ate controls. Dynamic morphs of portrait and lateral views between
the control and CS mean faces very clearly demonstrate the important
differences in facial characteristics in both males and females (see
Supplementary Movie S1 and S2).
When compared to the mean face of the male controls, the color-
distance-coded comparison of the mean CS male suggests a longer
and wider nose, a longer philtrum, retrognathia, fuller lips, a more bul-
bous nose, a more prominent and pointed chin and lifting of supra-
orbital ridges (Figure 2a). By viewing the dynamic comparisons of the
mean faces these face-shape differences are shown in a more dra-
matic manner. Additionally, a lengthening of the entire face becomes
visible. Figure 2b shows the results of a double-tailed t-test compari-
son where this is appropriate. Statistically significant differences
between male CS patients and age- and gender-matched controls
confirm the wider nose (p = .0003), longer philtrum (p = .0004) and
increased nose length (p = .011), whereas there is no obvious increase
in mouth width.
The static comparison (Figure 3a) as well as the dynamic morphs
in the Supplementary Material show similar but less pronounced facial
differences in the female cases. Whereas, patients show an upward/
backward displacement of the nose resulting in anteriorly facing
nostrils compared to the control group, both the lengthening of the
face and therefore nose as well as thickening of the lips are less signif-
icant. Additionally, the chin seems less pointed. Both male and female
individuals show no obvious increase in mouth width. The nose width
(p = .0003) is statistically significant when compared to age- and
gender-matched controls, whereas philtrum length (p = .032), nose
length (p = .325) and mouth width (p = .092) are not (Figure 3b).
In order to compensate for the wide age range (2–22 years) and
the changes in morphometric analysis according to age, we addition-
ally investigated differences in facial features in the following age-
and gender-specific CS subgroups compared to respectively matched
controls: Male subgroup 1 (age 2–5 years), male subgroup 2 (age
10–22 years), female subgroup 3 (age 2–5 years) and female subgroup
4 (age 10–22 years). Signature heat map comparisons between all four
subgroups and controls suggest that the pointiness of the chin
develops at a later age (>10 years) whereas periorbital fullness
decreases over time (Figure S4a-S7a). Retrognathia, lifting of supra-
orbital ridges and bulbousness of the nose develop early on. Whereas
younger male CS patients show a significantly wider nose (p = .0026),
longer philtrum (p = .0087) and increased nose length (p = .0079) com-
pared to healthy individuals, older male CS patients only reveal a sta-
tistically significant difference in nose width (p = .0061) and philtrum
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length (p = .0112) when compared with age- and gender-matched
controls suggesting a slight decrease or at least stagnation in overall
dysmorphism over age (Figure S4b and S5b). Similary, nose width of
female CS patients in young age shows statistical significance
(p = .0101), but becomes more equal to healthy individuals in older
age (p = .079). Philtrum length, on the other hand, is only significantly
increased in older female CS patients (p = .0036) (Figure S6b and
S7b). Notably, sample sizes in these subgroups are restricted and
results should therefore only be seen as indications of progression of
facial anomalies in CS.
3.4 | Facial growth and overall dysmorphism in CS
In a face DSM with mixed age range, the first principal component
(PC1) typically reflects growth and is highly correlated with age. Sepa-
rate linear regression of PC1 against age for gender-specific control
and CS subgroup (2–22 years) suggests face size is significantly
greater in patients (males: p < .0001; female: p = .0325) (Figure 4a).
However, care must be taken in this interpretation as the retrognathia
and open bite may exaggerate facial length in CS patients. On the
other hand, a majority of CS patients show increased body size and
macrocephaly at birth, hence an increased facial growth compared to
controls is to be expected. Additionally, this reflects observations
stated when comparing the average face of CS patients and controls
(Figure 1a,b).
When calculating PC1 for all four age- and gender-specific sub-
groups facial growth is still significantly increased in both male sub-
groups (age range 2–5 years: p = .0004, age range 10–22 years:
p = .001), whereas facial growth seems to become more similar to
healthy controls in female CS patients (age range 2–5 years:
p = .0713, age range 10–22 years: p = .0776) (Figure S8a,b).
The overall dysmorphism score was calculated as the square
root of the sum of squared differences of displacements in the sig-
nature heat map comparison with the mean of age- and sex-
matched controls. Firstly, this score suggests that facial dys-
morphism does not increase much over time in CS patients
(Figure 4b). However, a comparison between female and male
patients shows significantly more dysmorphism across all ages in
male patients (p = .0151). Calculation of signature weight in all four
age- and gender-specific subgroups confirms these observations
(Figure S8c).
F IGURE 1 Three-dimensional images of 20 Cantú
syndrome patients. Portrait and profile of average faces of
20 individuals with Cantú syndrome (b) and 143 healthy
controls (a) with same mean age. (c) Heat-mapped face
signatures showing normalized face shape differences
(displacement of surface points orthogonal to face surface
and parallel to three axes) compared with matched control
mean. The red/green/blue coloring reflects displacement
orthogonal to the surface in the first signature (red/green/
blue = contraction/coincidence/expansion) and in the
three axial signatures parallel to the colored arrows with
green = no displacement and maximal red-blue hues
reflecting two SDs or more. (d) Heat mapped face
asymmetry signatures of all investigated 20 Cantú
patients [Color figure can be viewed at
wileyonlinelibrary.com]
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3.5 | DSM analysis results in high levels of
discrimination between CS and other disorders with
similar facial dysmorphologies
According to previous publications (Grange et al., 2019), many CS
patients initially received other diagnoses, often based on coarse facial
features. This has been extremely stressful for parents who were
informed about a bad prognosis based on a wrong diagnosis. To
evaluate whether 3D imaging analysis can be successfully applied to
discriminate between disorders and thus avoid misdiagnoses, we com-
pared facial features of CS patients with readily available cohorts of
other genetic disorders with facial anomalies that have been mistaken
with CS-related anomalies in the past; namely Fabry disease
(FD) (n = 28) (Cox-Brinkman et al., 2007), Rasopathies (n = 33)
(Hammond et al., 2004), Williams syndrome (WS) (n = 83)
(Hammond & Suttie, 2012) and Rubinstein–Taybi syndrome (RTS)
F IGURE 2 Male-specific facial abnormalities in CS patients. (a) Portrait and profile views of the color-coded comparison of male CS patients
with the average of the male control group (n = 76, age range: 3.1–21 years). The color scale of all depicted heatmaps is equal to Figure 1. (b) A
scatter of age against different facial features is shown for a single DSM for a reduced face patch (no ears) for both age-matched controls and
male CS patients. Statistically significant differences between male CS patients and age- and gender-matched controls confirm a wider nose
(p = .0003), longer philtrum (p = .0004) and increased nose length (p = .011). DSM, dense surface model [Color figure can be viewed at
wileyonlinelibrary.com]
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(n = 34) (Menke et al., 2018). Notably, mucopolysacharidosis is the
most common misdiagnosis in CS based on similar facial appearance
(Grange et al., 2019), however there was no collection of 3D images
from a patient cohort available for comparison. For this purpose, sub-
groups of individuals with other syndromes were selected in terms of
age-range compatibility with the CS patients. Any individual's face can
be compared to variation between the average face of two
subgroups.
Figure 5 shows a simultaneous comparison along three axes:
mean control to mean CS; mean FD to mean Rasopathy and mean
RTS to mean WS. No overlap could be observed between the CS, FD
and RTS subgroups, but CS does share small similarities with
Rasopathy and WS patients.
Separate linear regressions of PC1 against age for CS and the
remaining disorder subgroups suggest both delay and diminished rate
of facial growth in all syndromes but CS. The difference in intercept
was highly statistically significant (CS/Rasopathies and CS/RTS,
p < .0001; CS/FD, p = .0021). When comparing CS to WS the slopes
differ significantly (p = .0014), but it was not possible to test whether
the intercepts differ significantly (Figure S9). These results are to be
expected considering the universal clinical observation of generalized
macrosomia, with large birth weight and length, as well as persistent
macrocephaly commonly reported in CS. In contrast, individuals with
WS (Carrasco, Castillo, Aravena, Rothhammer, & Aboitiz, 2005), FD
(Colon et al., 2017) and Rasopathies (Tajan, Paccoud, Branka,
Edouard, & Yart, 2018) generally show low birth weight. Similar obser-
vations could be made when comparing age-specific CS subgroups
(subgroup 1: age range 2–5, subgroup 2: age range 10–22) to age-
matched disease cohorts (Figure S10).
Calculation of the overall dysmorphism score for each individual
and separate linear regressions against age additionally suggest that
facial dysmorphism increases with age in all disorders but CS. The dif-
ference in slope was highly statistically significant when comparing CS
and Rasopathies (p = .0057). No statistical significance was found in
all other cases (CS/WS, p = .3; CS/RTS, p = .0862; CS/FD, p = .2780)
(Figure S11). When separating CS patients in subgroups according to
F IGURE 3 Female-specific facial
abnormalities in CS patients.
(a) Portrait and profile views of the
color-coded comparison of female CS
patients with the average of the
female control group (n = 69, age
range: 2.4–22.4 years). The color
scale of all depicted heatmaps is
equal to Figure 1. (b) A scatter of age
against different facial features is
shown for a single DSM for a reduced
face patch (no ears) for both age-
matched controls and female CS
patients. Statistically significant
differences between female CS
patients and age- and gender-
matched controls confirm a wider
nose (p = .0003). DSM: Dense surface
model [Color figure can be viewed at
wileyonlinelibrary.com]
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F IGURE 4 Facial growth and
overall dysmorphism in CS. (a) A
scatter of age against PC1 is shown
for a single DSM for a reduced face
patch (no ears) for both the control
and CS subgroups. The scatter is
annotated by separate linear
regression lines for each subgroup.
PC1 reflects facial growth. Male
control group includes n = 76
individuals with an age range of
3.1–21.0 years; female control group
includes n = 69 subjects ranging from
2.5 to 22.4 years of age. (b) A scatter
of age against signature weight is
shown for a single DSM for a reduced
face patch (no ears) for male and
female CS subgroups. Signature
weight is a rough estimate of facial
dysmorphism. DSM, dense surface
model; PCA, principal component
[Color figure can be viewed at
wileyonlinelibrary.com]
F IGURE 5 Comparison Of Mean Faces Along 3 Axes. Comparison between mean control to mean CS; mean FD to mean Rasopathy and
mean RTS to mean WS. (a) CS, Rasopathy and WS are depicted. (b) CS, FD and RTS are depicted. Sample size, CS, n = 20 (age range:
2.7–22.0 years); Rasopathies, n = 33 (age range: 2.3–21.9 years); WS, n = 83 (age range: 2.1–19.7 years); RTS, n = 59 (age range: 2.0–21.6 years);
FD, n = 28 (age range: 3.4–22.8 years). CS, Cantú syndrome; FD, Fabry disease; RTS, Rubinstein–Taybi syndrome; WS, Williams syndrome [Color
figure can be viewed at wileyonlinelibrary.com]
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age, overall dysmorphism of young CS patients is significantly
decreased compared to individuals with WS (Figure S12).
4 | DISCUSSION
In this study, facial dysmorphism in patients with CS is objectively
assessed by 3D dense surface modeling and anthropometric analysis,
revealing facial dysmorphic features in male and female patients. The
most prominent facial anomalies shared by both genders are a broad-
ened nasal bridge and wider nose, narrow supra-orbital arches, epi-
canthal folds, a longer philtrum, thick lips, and retrognathia. Male
patients additionally reveal lengthening of the face and nose which is
less pronounced in females who, on the other hand, show an upward
and backward displacement of the nose, anteverted nares, and lifting of
supra-orbital ridges. The majority of all CS-related facial features seem
to develop early on. Merely, the pointed chin and the longer philtrum in
female patients are only revealed in older age. Facial anomalies tend to
remain until the age of at least 22 with only the nose width of female
CS patients normalizing after childhood.
Face size and growth in CS patients, interpreted by PC1 in the
model, is always greater compared to age-matched controls. Overall
facial dysmorphism, is significantly higher in male CS patients com-
pared to females but unlike the other syndromes investigated, it barely
increases or even stagnates with age in all studied subgroups. Notably,
we would like to point out that all analysis performed in the four age-
and gender-specific CS subgroups can merely be seen as an indication
of facial development in CS since the subject numbers are small (3–7
patients) and therefore miss statistical robustness. Thus, we strongly
suggest to primarily focus on data aquired from CS subgroups con-
taining all male or female patients as shown in Figures 2 and 3. In order
to properly assess changes in facial features in different CS age groups
one would require a cohort with significantly more subjects.
Our results are mostly in line with the features described in vari-
ous clinical reports that assessed facial characteristics of CS patients
based on medical photography (Roessler et al., 2018; Scurr et al.,
2011). However, increase in mouth width which has been previously
reported in the literature (Grange, Nichols, & Singh, 2014; Roessler
et al., 2018) was not observed applying 3D image analysis. Hence, we
demonstrate that 3D imaging recognizes common facial anomalies
observed in CS patients. Since the results generated in this study are
produced by objective quantitative analysis and are thus not ham-
pered by inter-observer variability, the applied approach enables a
more reliable assessment and quantification of facial anomalies
observed in CS patients. Moreover, we include comparison of both
male and female CS patients with respective controls as well as evalu-
ation of facial growth and overall dysmorphism.
Notably, our study cohort only includes Caucasians, originating
from both the Netherlands and the United States with an age range of
2.7–22.0 years, which resembles the overall patient demographic
reported in literature so far (Grange et al., 2019). Even though all
applied control subjects in this study are also Caucasian, they originate
from two European populations of close phylogenetic and geographic
proximity, the UK and The Netherlands (Figure S2). Even though previ-
ous studies have shown facial differences in different adult Caucasian
populations (Hopman, Merks, Suttie, Hennekam, & Hammond, 2014),
we do not expect these to be present in younger individuals.
The uneven age distribution of patients, which can be observed in
our CS cohort, might be seen as a limitation when making simple
anthropometric comparisons with controls but for shape specific con-
siderations like face signature each individual is normalized against a
sex-and-age matched set of controls which is more reliable.
It would be of interest to perform a similar study in CS patients
with an increased age as well as from non-European ancestry, which
would require a larger cohort as is identified currently. Additionally,
3D face morphometry of CS patients could be compared to healthy
siblings as similarity and variability between healthy and diseased sib-
lings might highlight the real face morphometry of the disorder. This,
however, would require capturing 3D images of healthy siblings of the
same sex and a similar age which might be a challenge given the over-
all rarity of CS.
Another interesting prospect of 3D face shape models is the
appliance in genotype–phenotype studies. So far, no obvious differ-
ences in frequency or degree of craniofacial dysmorphology, hyper-
trichosis, or skin appearance depending on the site of the ABCC9
variant could be observed in CS individuals. Also, cardiovascular and
neurological anomalies were similar across the ABCC9 variant loca-
tions (Grange et al., 2019). Even within families containing multiple
affected members, there is highly variable expression of CS features,
comparable with other autosomal dominant conditions (Grange et al.,
2019; Roessler et al., 2018). 3D imaging technologies offer a way to
investigate genotype–phenotype correlations in terms of facial fea-
tures. However, one would have to increase cohort size in order to a
perform reliable analysis.
Notably, it would be interesting to acquire and analyze 3D facial
photographs of patients harboring a variant in KCNJ8 because they
may potentially have phenotypic differences that can only be distin-
guished by quantitative evaluation instead of by eye. However, since
at the moment only two patients with a CS-associated variant in
KCNJ8 are known (Brownstein et al., 2013; Cooper et al., 2014) this
would be of interest once a larger cohort has been acquired in the
future. Notably, it is speculated that such variants might frequently be
lethal (Grange et al., 2019).
Clinical geneticists often refer to facial differences and features
that offer clues to diagnosis. Articulating those differences can be
challenging, especially if an individual's face shows a mild facial pheno-
type or if morphological characteristics are manifested in only part of
the face. These complications can lead to misdiagnosis of patients.
According to a recent report on 74 patients from the ICSR, 41% of
participating CS patients initially received other diagnoses based on
various primarily assessed features, including a lysosomal storage dis-
order such as mucopolysaccharidosis or Pompe disease based on neo-
natal cardiomegaly (Grange et al., 2019). The majority of misdiagnoses
were based on facial dysmorphology and hypertrichosis and could
however not be confirmed by additional genetic of metabolic testing.
Since these misdiagnoses implicate a completely different prognosis
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and life expectancy, earlier CS face recognition could prevent unnec-
essary stress for parents.
By comparing facial characteristics of CS with patient cohorts
whose facial anomalies have been mistaken with CS in the past we
demonstrate that 3D imaging analysis can be successfully applied to
delineate between syndromes and thus avoid further misdiagnoses. It
would be of interest to perform a similar comparison between CS and
MPS patients in the future. Notably, congenital hypertrichosis, also
observed in all CS patients (Grange et al., 2019), can sometimes be
applied as clear discriminator between CS and other mentioned syn-
dromes, if severe enough.
Most importantly, the described 3D imaging technique reveals
multiple advantages including practicality, availability and low costs.
3D cameras and appropriate computer software for analysis are avail-
able in every clinic that makes assessing facial morphology via 3D
imaging quick and cheap. Hence, the implementation of this in general
practice for clinical diagnosis of CS patients but also other disorders
with a facial component is feasible.
Recent innovations based on 2D technologies combined with
computer vision and deep learning algorithms also hold promise to be
worthwhile in diagnosis of genetic disorders with facial components
(Gurovich et al., 2019; van der Donk et al., 2019). Although 2D images
are more readily available, they are subject to greater variation in
quality and pose due to projection distortion, and more sophisticated
analysis is required to extract the discriminating features. Thus, a sig-
nificantly increased number of images is required to train the pattern
recognition algorithms. Therefore, 2D technologies may represent a
considerable alternative in clinics to successfully diagnose CS and
other genetic disorders with facial anomalies in the future, but it still
remains to be seen which approach has more potential to be
established in a stable fashion.
5 | CONCLUSION
In conclusion, we report a valid method for quantification of facial
dysmorphic features in CS.
Although facial dysmorphism in CS can be clinically recognizable,
an objective, quantitative evaluation is especially valuable when
assessing phenotypically or genotypically unusual cases.
The genes associated with CS have only recently been identified.
Hence, we suspect there may be more affected individuals—particularly
older patients—who have not received genetic testing and therefore
remain undiagnosed. We demonstrate that 3D imaging analysis can be
confidently applied to unravel characteristic facial features of CS and
successfully discriminate between the syndrome and other genetic dis-
orders it has been confused with in the past due to facial similarities.
This will help in diminishing parental anxiety related to misdiagnoses.
In the future, 3D-based analysis will enable the recognition of CS
facial characteristics in patients who have not had an adequate clinical
diagnosis. Subsequent molecular analysis of such patients may iden-
tify mutations and in combination with detailed facial analysis enable
unequivocal identification of causative genes. Considering the current
efforts to develop a pharmacological treatment for CS (Ma et al.,
2019; McClenaghan et al., 2019), 3D technology additionally may
enable the evaluation and quantitative measurement of effective
response to therapy options in the future which will possibly lead to a
decrease in coarseness of the face.
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